Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock?Zacks Investment Research · Oct 6, 2026
Comparing Enanta Pharmaceuticals (NASDAQ:ENTA) and Amphastar Pharmaceuticals (NASDAQ:AMPH)Defense World · Oct 6, 2026
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Average Rating of “Reduce” from AnalystsDefense World · Sep 30, 2026
Insider Selling: Amphastar Pharmaceuticals (NASDAQ:AMPH) EVP Sells $239,400.00 in StockDefense World · Sep 20, 2026
Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare ConferencePRNewsWire · Sep 1, 2026
3 Generic Drug Stocks to Watch Amid Improving Industry TrendsZacks Investment Research · Aug 27, 2026Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise. The company is engaged in the creation, production, commercialization, and distribution of both generic and proprietary pharmaceutical products, which include injectables, inhalants, and intranasal formulations. Its market presence extends across the United States, China, and France.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 6, 2026 | $0.62 | $0.91 | Beat |
| May 7, 2026 | $0.70 | $0.42 | Miss |
| Feb 26, 2026 | $0.90 | $0.73 | Miss |
| Nov 6, 2025 | $0.77 | $0.93 | Beat |
| Aug 7, 2025 | $0.71 | $0.85 | Beat |
| May 7, 2025 | $0.66 | $0.74 | Beat |